ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) Loses Momentum on New Dilution
[[tagnumber 0]][[tagnumber 1]]The chart performance of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) for the first half of October can be divided into two phases – before and after the PO announcement. Needless to say, both periods...